Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith E Lowry

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Plos One|December 13, 2021
Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trialMaria F Paton, John Gierula, Judith E Lowry, et al.
BMJ Open|July 20, 2019
Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trialMaria F Paton, John Gierula, Haqeel A Jamil, et al.
Journal of the American Heart Association|October 30, 2018
Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection FractionBen N Mercer, Aaron Koshy, Michael Drozd, et al.
Pacing and Clinical Electrophysiology : PACE|February 20, 2026
Exercise Capacity and the Force Frequency Relationship in Multi-Point Versus Single-Point Pacing: A Randomized TrialNawaz Z Safdar, Ria M Gadani, Charlotte A Cole, et al.
Diabetes & Vascular Disease Research|April 16, 2024
Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progressionJohn Gierula, Sam Straw, Charlotte A Cole, et al.
Circulation|April 18, 2020
Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II StudyJohn Gierula, Judith E Lowry, Maria F Paton, et al.
Nature Medicine|September 19, 2024
Echocardiographic screening for heart failure and optimization of the care pathway for individuals with pacemakers: a randomized controlled trialMaria F Paton, John Gierula, Haqeel A Jamil, et al.
Circulation. Cardiovascular Imaging|July 16, 2025
Assessing LV Contractility Identifies Populations With Preserved Ejection Fraction at Risk of Adverse Heart Failure OutcomesSam Straw, Oliver I Brown, Charlotte A Cole, et al.
Journal of the American College of Cardiology|April 9, 2016
Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE StudyKlaus K Witte, Rowena Byrom, John Gierula, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|November 20, 2018
Prospective evaluation and long-term follow-up of patients referred to secondary care based upon natriuretic peptide levels in primary careJohn Gierula, Richard M Cubbon, Maria F Paton, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Plos One|December 13, 2021
Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trialMaria F Paton, John Gierula, Judith E Lowry, et al.
BMJ Open|July 20, 2019
Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trialMaria F Paton, John Gierula, Haqeel A Jamil, et al.
Journal of the American Heart Association|October 30, 2018
Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection FractionBen N Mercer, Aaron Koshy, Michael Drozd, et al.
Pacing and Clinical Electrophysiology : PACE|February 20, 2026
Exercise Capacity and the Force Frequency Relationship in Multi-Point Versus Single-Point Pacing: A Randomized TrialNawaz Z Safdar, Ria M Gadani, Charlotte A Cole, et al.
Diabetes & Vascular Disease Research|April 16, 2024
Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progressionJohn Gierula, Sam Straw, Charlotte A Cole, et al.
Circulation|April 18, 2020
Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II StudyJohn Gierula, Judith E Lowry, Maria F Paton, et al.
Nature Medicine|September 19, 2024
Echocardiographic screening for heart failure and optimization of the care pathway for individuals with pacemakers: a randomized controlled trialMaria F Paton, John Gierula, Haqeel A Jamil, et al.
Circulation. Cardiovascular Imaging|July 16, 2025
Assessing LV Contractility Identifies Populations With Preserved Ejection Fraction at Risk of Adverse Heart Failure OutcomesSam Straw, Oliver I Brown, Charlotte A Cole, et al.
Journal of the American College of Cardiology|April 9, 2016
Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE StudyKlaus K Witte, Rowena Byrom, John Gierula, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|November 20, 2018
Prospective evaluation and long-term follow-up of patients referred to secondary care based upon natriuretic peptide levels in primary careJohn Gierula, Richard M Cubbon, Maria F Paton, et al.
Pageof 3